Causal therapy of Parkinson's disease with anle138b, a novel protein 
aggregation inhibitor.

Levin, J.; Wagner, J.; Ryazanov, S.; Leonov, A.; Shi, S.; Schmidt, F.; Prix, C.; Bertsch, U.; Mitteregger-Kretzschmar, G.; Geissen, M.; Hischberger, T.; Tavan, P.; Pilger, J.; Zweckstetter, M.; Frank, T.; Baehr, M.; Weishaupt, J.; Uhr, M.; Urlaub, H.; Teichmann, U.; Boetzel, K.; Groschup, M.; Kretzschmar, H. A.; Griesinger, C.; Giese, A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Conference Paper

Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor.

MPS-Authors

/persons/resource/persons45923

Ryazanov, S.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15438

Leonov, A.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons16093

Zweckstetter, M.
Research Group of Protein Structure Determination using NMR, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15947

Urlaub, H.
Research Group of Bioanalytical Mass Spectrometry, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15147

Griesinger, C.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Levin, J., Wagner, J., Ryazanov, S., Leonov, A., Shi, S., Schmidt, F., et al. (2011). Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. Movement Disorders, 26(Supplement 2), S21-S21.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000F-4202-0

Abstract

There is no abstract available